(FLCH) Franklin FTSE China - Ratings and Ratios

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US35473P8196 • China Region

FLCH: Chinese, Stocks, Shares

The Franklin FTSE China ETF (NYSE ARCA: FLCH) is designed to track the performance of the FTSE China Index, which focuses on large- and mid-capitalization Chinese companies. Under normal market conditions, the fund invests at least 80% of its assets in the indexs component securities, including H-Shares, B-Shares, and A-Shares, as well as depositary receipts representing such securities. The fund is non-diversified, meaning it can concentrate its investments in a smaller number of securities, which may increase volatility. FLCH provides exposure to a broad range of Chinese equities, offering a way for investors to gain access to the Chinese market through a single ETF.

As of the latest data, FLCH has an average trading volume of 72,355 shares over the past 20 days, with a last price of $20.61. The funds short-term moving average (SMA 20) is $20.45, while its mid-term (SMA 50) and long-term (SMA 200) moving averages are $19.20 and $17.92, respectively. The Average True Range (ATR) is 0.37, indicating moderate volatility. With assets under management (AUM) of $166.58 million, FLCH is a moderately sized ETF targeting investors seeking exposure to the Chinese equity market.

Based on the current technical indicators, FLCH is expected to maintain its upward momentum in the next three months. The SMA 20 crossing above the SMA 50 suggests a bullish short-term outlook, while the SMA 200 remains below, indicating long-term growth potential. The ATR of 0.37 suggests controlled volatility, which may stabilize price movements. The funds AUM of $166.58 million reflects moderate investor interest, which could support liquidity in the coming months.

From a fundamental perspective, FLCHs exposure to large- and mid-cap Chinese stocks positions it to benefit from the countrys economic recovery and policy support. The inclusion of H-Shares, B-Shares, and A-Shares provides a diversified approach to capturing growth across different segments of the Chinese market. However, risks such as regulatory changes, geopolitical tensions, and market volatility could impact performance. Overall, FLCH is well-positioned to capitalize on Chinas equity market growth over the next quarter.

Additional Sources for FLCH ETF

FLCH ETF Overview

Market Cap in USD 166m
Category China Region
TER 0.19%
IPO / Inception 2017-11-02

FLCH ETF Ratings

Growth Rating -7.65
Fundamental -
Dividend Rating 55.7
Rel. Strength 17.5
Analysts -
Fair Price Momentum 19.75 USD
Fair Price DCF -

FLCH Dividends

Dividend Yield 12m 2.74%
Yield on Cost 5y 2.52%
Annual Growth 5y 12.70%
Payout Consistency 83.0%

FLCH Growth Ratios

Growth Correlation 3m 13.7%
Growth Correlation 12m 73.9%
Growth Correlation 5y -70.7%
CAGR 5y -0.54%
CAGR/Max DD 5y -0.01
Sharpe Ratio 12m 0.74
Alpha 21.26
Beta 0.609
Volatility 36.31%
Current Volume 30.5k
Average Volume 20d 76.6k
What is the price of FLCH stocks?
As of April 25, 2025, the stock is trading at USD 20.41 with a total of 30,527 shares traded.
Over the past week, the price has changed by +5.71%, over one month by -6.25%, over three months by +9.32% and over the past year by +28.72%.
Is Franklin FTSE China a good stock to buy?
Neither. Based on ValueRay Analyses, Franklin FTSE China is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of -7.65 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of FLCH as of April 2025 is 19.75. This means that FLCH is currently overvalued and has a potential downside of -3.23%.
Is FLCH a buy, sell or hold?
Franklin FTSE China has no consensus analysts rating.
What are the forecast for FLCH stock price target?
According to ValueRays Forecast Model, FLCH Franklin FTSE China will be worth about 21.8 in April 2026. The stock is currently trading at 20.41. This means that the stock has a potential upside of +6.86%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 21.8 6.9%